You are here


Research from Iannis Aifantis and colleagues at NYU School of Medicine finds vitamin C may work as a therapy for some leukemias and myelodysplastic syndromes by activating TET2.

Jian Feng’s group identifies a pathophysiological change in neurons derived from Parkinson’s patients harboring parkin mutations

Regenerative medicine company receives venture capital funding for Parkinson’s research